These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27340673)

  • 41. Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists.
    Canonica GW; Passalacqua G; Incorvaia C; Cadario G; Fiocchi A; Senna G; Rossi O; Romano A; Scala E; Romano C; Ingrassia A; Zambito M; Dell'Albani I; Frati F
    Allergy Asthma Proc; 2014; 35(1):43-6. PubMed ID: 24433596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients.
    Hüser C; Dieterich P; Singh J; Shah-Hosseini K; Allekotte S; Lehmacher W; Compalati E; Mösges R
    Allergy; 2017 Jan; 72(1):77-84. PubMed ID: 27068870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life.
    Bahbah F; Gentil C; Sousa-Pinto B; Canonica GW; Devillier P; Pfaar O; Bousquet J
    Allergy; 2023 Apr; 78(4):1113-1116. PubMed ID: 36226843
    [No Abstract]   [Full Text] [Related]  

  • 44. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.
    Didier A; Wahn U; Horak F; Cox LS
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1309-24. PubMed ID: 25205329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local Side Effects of Sublingual and Oral Immunotherapy.
    Passalacqua G; Nowak-Węgrzyn A; Canonica GW
    J Allergy Clin Immunol Pract; 2017; 5(1):13-21. PubMed ID: 27527548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 47. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy.
    Larenas-Linnemann DE
    Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
    Cavaliere C; Incorvaia C; Begvarfaj E; Orlando MP; Turchetta R; Musacchio A; Ralli M; Ciofalo A; Greco A; de Vincentiis M; Masieri S
    Expert Opin Drug Saf; 2021 Mar; 20(3):259-264. PubMed ID: 33427529
    [No Abstract]   [Full Text] [Related]  

  • 50. Tailored Sublingual Immunotherapy in a Monosensitized Child with Natural Rubber Latex Allergy.
    Giovannini M; Mori F; Barni S; Liccioli G; Sarti L; Novembre E
    Pharmacology; 2020; 105(11-12):719-722. PubMed ID: 32894843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of sublingual immunotherapy.
    Ciprandi G; Marseglia GL
    J Biol Regul Homeost Agents; 2011; 25(1):1-6. PubMed ID: 21382267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The promise of sublingual and other immunotherapy options for infants and toddlers with food allergy.
    Anagnostou A; Upton JEM; Chinthrajah RS
    J Allergy Clin Immunol; 2024 Jan; 153(1):95-97. PubMed ID: 37992817
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral and sublingual immunotherapy for egg allergy.
    Romantsik O; Tosca MA; Zappettini S; Calevo MG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010638. PubMed ID: 29676439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sublingual immunotherapy].
    Goto M
    Arerugi; 2014 Feb; 63(1):65-6. PubMed ID: 24754098
    [No Abstract]   [Full Text] [Related]  

  • 56. Undertreatment of allergy: exploring the utility of sublingual immunotherapy.
    Emanuel IA; Parker MJ; Traub O
    Otolaryngol Head Neck Surg; 2009 May; 140(5):615-21. PubMed ID: 19393398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 58. Current possibilities and future perspectives for improving efficacy of allergen-specific sublingual immunotherapy.
    Sadeghi M; Keshavarz Shahbaz S; Dehnavi S; Koushki K; Sankian M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108350. PubMed ID: 34782275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [ROLE OF DENDRITIC CELLS IN PROTECTIVE SUBLINGUAL IMMUNOTHERAPY AGAINST ALLERGY].
    Miyanaga N; Takagi H; Tono T; Sato K
    Arerugi; 2021; 70(8):931-935. PubMed ID: 34588351
    [No Abstract]   [Full Text] [Related]  

  • 60. Variation in allergen content in sublingual allergen immunotherapy with house dust mites.
    Moreno Benítez F; Espinazo Romeu M; Letrán Camacho A; Mas S; García-Cózar FJ; Tabar AI
    Allergy; 2015 Nov; 70(11):1413-20. PubMed ID: 26185961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.